Kerry Group (KRZ) Consumer Analyst Group of New York Conference (CAGNY) 2026 summary
Event summary combining transcript, slides, and related documents.
Consumer Analyst Group of New York Conference (CAGNY) 2026 summary
20 Feb, 2026Strategic execution and business transformation
Maintains a strong track record of double-digit EPS CAGR, with high single-digit or greater constant currency EPS growth in eight of the last ten years, and consistent outperformance of market volume growth by 300bps.
Transformed into a pure-play taste and nutrition company, divesting non-core businesses and investing €3bn in science and technology from 2018–2025.
Implements Accelerate 2.0 for manufacturing, supply chain, and digital excellence, targeting €100m annual savings by 2028.
Prioritizes capital allocation to reinvestment, dividends, M&A, and share buybacks, supported by strong cash generation and investment grade rating.
Recent developments include a new biotechnology center in Germany, geographic expansion in Africa and Middle East, and new innovation centers in Dubai, Frankfurt, and Jakarta.
Market dynamics and growth opportunities
Food and beverage markets remain highly dynamic, with growth concentrated in high-protein, ready-to-drink coffee, poultry, and supplements.
Over 60% of food and beverage activity involves product reformulation, driven by cost reduction and clean label demand.
Expands in the Americas and APMEA, with APMEA revenue expected to nearly double from €850m in 2015 to over €1.6bn in 2025.
Responds to regulatory and consumer trends driving demand for cleaner labels, sustainability, and nutrition/wellness.
Local investments and technology give structural advantage in high-growth regions like Southeast Asia, Middle East, and Africa.
Innovation and biotechnology leadership
Biotechnology and biofermentation enable scalable, resource-efficient solutions for cleaner labels, improved nutrition, and sustainability.
40% of taste solutions are enabled by fermentation; portfolio includes enzymes, biopharma, and food protection systems.
Recent innovations include fermentation-derived sweet and salt reduction, new prebiotic/postbiotic products, and enzyme systems for natural sweetness.
Integrated solutions address complex customer needs in protein, shelf life, taste, and cost management.
Examples include clean label meat snacks, high-protein beverages, sodium and sugar reduction in bakery, and shelf life extension for chicken products.
Latest events from Kerry Group
- Sustainable nutrition, innovation, and strong financials drive global growth and ESG leadership.KRZ
Investor presentation19 Mar 2026 - Strong volume and EPS growth, margin expansion, and innovation investments drive outlook.KRZ
Q4 202517 Feb 2026 - Upgraded EPS guidance, strong margin expansion, and robust T&N growth drive H1 outperformance.KRZ
Q2 20242 Feb 2026 - Q3 saw strong volume and margin growth, with full-year EPS guidance reaffirmed.KRZ
Q3 202418 Jan 2026 - Sale of Kerry Dairy Ireland for €500m will enhance margins, growth, and sustainability.KRZ
Investor Update15 Jan 2026 - Strong 2024 growth, margin expansion, and positive 2025 outlook after Dairy Ireland divestment.KRZ
Q4 20248 Jan 2026 - Targets high-single-digit EPS growth and 19-20% EBITDA margin by 2028, driven by innovation.KRZ
Consumer Analyst Group of New York Conference (CAGNY) 20258 Jan 2026 - Q1 2025 saw 3.1% volume growth, 90bps margin expansion, and EPS guidance maintained.KRZ
Q1 202525 Dec 2025 - 3.0% volume growth, 100bps margin expansion, and strong cash flow support full-year outlook.KRZ
Q2 20253 Nov 2025